ABSTRACT Objective: Visceral leishmaniasis (VL) is endemic in all Mediterranean countries including Turkey, and children are at greater risk than adults in endemic areas. In VL patients, serological assays are considered to be sensitive for the diagnosis and/or follow up. The aim of this study was to assess the usefulness of serology for following up of childhood VL in Turkey. Methods: Sera obtained from twenty parasitologically confirmed children with VL were tested using IFAT and ELISA. The patients were monitored clinically and serologically (range: 20-500 days) during and after treatment. All VL patients were treated with meglumine antimonate. Results: Anti-Leishmania antibodies in successfully treated VL patients showed a steep decline but, in three patients who had relapsed, an increase was detected. Significantly lower values were observed after treatment with both serological techniques. Mean ELISA optical density values before and after treatment were: 0.78±0.36 (0.26-1.76) and 0.38±0.24 (0.09-0.83) respectively, (p<0.001) and mean IFAT values (log 10 transformed titers) before and after treatment were: 3.02±0.90 (1.81-4.51) and 2.16±0.75 (1.20-3.90) respectively, (p<0.001). Conclusion: ELISA and IFAT are valuable not only for diagnosis but also for monitoring of drug therapy in childhood visceral leishmaniasis as rapid and non-invasive techniques. (Turkiye Parazitol Derg 2011; 35: 125-8) (Turkiye Parazitol Derg 2011; 35: 125-8) 
INTRODUCTION
Leishmaniasis, a vector-born disease caused by obligative intracellular protozoa of the genus Leishmania, is capable of causing a spectrum of clinical syndromes affecting millions of people in endemic areas of the tropics and subtropics. Visceral leishmaniasis (VL) is the most severe form and causes large-scale epidemics with a high fatality rate and is endemic in all Mediterranean countries including Turkey Children are at greater risk than adults in endemic areas (1, 2) .
In VL patients, serological assays are considered to be sensitive for the diagnosis and/or follow-up of visceral leishmaniasis. The aim of this study was to assess the usefulness of serology for following up of childhood VL in Turkey (2) (3) (4) (5) (6) . The most common methods of diagnosing VL are classical parasitological methods such as microscopical direct examination and in vitro culture of bone marrow and/or splenic aspirates (7) . As these techniques require invasive procedures and are difficult to repeat for followup of patients, an easy, rapid, and non-invasive method would be valuable. Therefore, we conducted a study among all children hospitalized for VL to assess the usefulness of IFAT and ELISA tests for follow-up of VL in childhood.
METHODS
The laboratories in the Department of Parasitology of Ege University Medical School have served as the National Reference Laboratory for the diagnosis of leishmaniasis and around 150 sera and/or bone marrow samples obtained from patients suspected by clinicians according to clinical signs/symptoms as having VL have being sent by different hospitals. In the laboratory, different parasitological and serological diagnostic techniques for leishmaniasis such as direct microscopy of bone marrow samples, inoculation to NNN culture, Indirect Fluorescent Antibody Test (IFAT), ELISA and rK39 dipstick test have been used. At the time the present study was carried out, only conventional PCR was applicable but, in the last several years the others (real-time PCR, sequencing, RFLP) have also become available.
For the present study, 20 pediatric visceral leishmaniasis patients diagnosed as VL by IFAT and ELISA were selected. The selection criteria were; (i) sera and bone marrow samples being available, (ii) at least three clinical signs are suitable for VL, (iii) immunocompetence, (iv) between the ages 1 and 14, (v) easy to access, (vi) approval of informed consent form by his/her parents.
The first samples were received before the treatment and the subsequent samples were requested during and after treatment. During the monitoring period, the medical information about the patients was requested from their physicians. If a relapse episode was suspected, samples were taken during the active phase. The time schedule was varied for each patient (range: 20 -500 days). The patient's biochemical results were not included in the study because of difficulties in accessing the results.
Culture: Between 50 and 100 micro liters of bone marrow aspirate was inoculated into NNN medium, kept at 24°C and examined by light microscopy every week for the presence of promastigotes for two months.
Microscopy:
The smear samples prepared from bone marrow aspirate were stained with Giemsa stain. Two experienced researchers examined each slide for at least 30 minutes looking for amastigotes independently.
Serology: The first (in the time of diagnosis) and subsequent serum samples (during follow-up) were tested individually and then all samples were tested in parallel for confirmation of the serological results. The serum samples were stored at -30 0 C until use.
IFAT was carried out using promastigotes from local L. infantum zymodeme MON-1 stocks obtained by mass culturing in RPMI-1640 containing 10% FCS. The IFAT was performed using standard procedures for humans (8) . Slides were stained with FITClabeled anti-human IgG conjugate (BioMerieux 75692) for sera. Titers ≥1:128 were scored as positive for both groups of sera while 1/64 titer was accepted as borderline in reference to relevant publications (9, 10) .
ELISA was performed as explained previously (11), except for the whole lysate promastigote antigen, using 1/100 single serum dilution. The optical density was measured at 405 nm and the subjects were considered as positive when the OD was >0.300, which represents the mean plus 3xSD absorbencies obtained in sera from individuals accepted without exposure to Leishmania.
PCR:
The DNA isolation and conventional PCR were applied as described previously (12) . Briefly, the DNA extraction was done using the phenol-chloroform method and for the conventional PCR, 13A (5' GTG GGG GAG GGG CGT TCT 3') and 13B (5' ATT TTA CAC CAA CCC CCA GTT 3') primers were used. 
RESULTS
Of the 20 paediatric patients, predominantly from the Aegean region of Turkey, 70% were male and 30% female. The patients' median age was 46, 6 months (range, 5 months-14 years); 16 patients (80%) were aged ≤5 years. Fifty-three sera and 23 bone marrow (BM) samples taken from 20 children were tested.
With successful therapy, antibody titers declined steeply during follow-up. Three patients who showed increased titers of antibodies were treated successfully with a second cure of meglumine antimoniate. Parasitological and serological results were summarized in Table 1 . Mean ELISA optical density values before and after treatment were: 0.78±0.36 (0.26-1.76) and 0.38±0.24 (0.09-0.83) respectively; (p<0.001). Cut-off point was 0.300 OD. Mean IFAT values (log 10 transformed titers) before and after treatment were: 3.02±0.90 (1.81-4.51) and 2.16±0.75 (1.20-3.90) respectively; (p<0.001). Cut-off point was 2.11 (Fig 1, 2) . Among 20 patients, relapses were detected in three patients (no: 2, 8, 19) and occurred between 90 and 480 days after the primary diagnosis. The antibody titers of these patients gave an increase compared with the previous titers during follow up with ELISA and/or IFAT. They showed clinical symptoms and their peripheral blood samples were also found to be positive by PCR. Interestingly, the titers in ELISA in two patients (8 and 19) after the relapse were higher than the first diagnosis values, while the titer was lower in patient 2.
DISCUSSION
Leishmaniasis is a group of vector borne disease, affecting 98 countries or territories, with more than 350 million people at risk. Visceral leishmaniasis (VL) is the most serious form, which is fatal if left untreated, and the annual incidence is estimated as 500,000 cases worldwide (1, 13) . In endemic areas, the disease tends to be relatively chronic, and children are especially affected. Until recently, the age group most affected by endemic visceral leishmaniasis caused by L. infantum in southern Europe, North Africa and West and Central Asia was 1-4 years (13). The median age of our patients was 46, 6 months, (range:5 months -14 years) and 80% of the children were younger than ≤5 years. These findings were also similar to those reported in the other Mediterranean countries and Turkey (13) (14) (15) (16) (17) (18) (19) (20) .
Visualization of the amastigote form of the parasite by microscopic examination of tissue aspirates is the classical confirmatory test for Visceral leishmaniasis. Culturing of blood or organ aspirates increases the sensitivity of diagnosis (13) . Several serologic tests varying in terms of sensitivity and specificity are the most practical way of diagnosing VL infections (2-6). On the other hand, different PCR assays have been developed for diagnosing and monitoring leishmaniasis. This technique has been shown to be more useful than conventional diagnostic methods, due to its greater sensitivity (21) (22) (23) (24) .
In this study, with successful therapy, antibody titers declined steeply during follow-up. Among 20 patients, relapses were detected in three patients. The antibody titers of these patients showed an increase compared with the previous titers during follow up with ELISA and/or IFAT. They showed clinical symptoms and their peripheral blood samples were also found to be positive by PCR. This is the first report of follow-up by serological tests of pediatric visceral leishmaniasis in Turkey. ELISA and IFAT are simple, inexpensive, non-invasive and valuable in monitoring drug therapy and detecting relapse of VL among children. The sharp decline in titers correlated well with a definite cure and can be applied to the hospital routine, whereas in relapsing patients a rise after an initial fall was a good indicator.
We recommend the use of IFAT and ELISA tests for follow up of visceral leishmaniasis. We conclude that primary diagnosis and post therapeutic monitoring by IFAT and ELISA tests for children is recommended.
